Cancer-cell growth and survival
Potential benefit studied: Slower cell multiplication and activation of programmed cell death
Supporting researchThis is cancer research, not a product treatment claim. These studies do not establish that Longevity or Mobility prevents, treats or cures cancer.
Laboratory and animal research found that curcumin reduced cancer-cell proliferation and activated programmed cell death through investigated signalling pathways.
A 2012 study exposed human bronchial and lung-cancer cell lines to curcumin and examined proliferation and STAT3 signalling. Twelve mice also received experimental injections for three or nine days, with lung-tissue markers assessed.
These experiments did not test Longevity, Mobility or the Daily Pair. Cell-culture concentrations and animal injections cannot establish an effective retail capsule dose. Cancer treatment decisions belong with the oncology team.
The doses above describe research, not personal dosing instructions. Ingredient studies do not diagnose symptoms or establish medical suitability. Discuss medicines, existing conditions and treatment decisions with an appropriate healthcare professional.